Can a simple drug make colorectal surgery safer?

NCT ID NCT06657924

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether giving tranexamic acid (TXA) before and after major colorectal surgery can reduce bleeding and the need for blood transfusions. About 394 adults having inpatient colorectal surgery will either receive TXA or not. The trial also checks if TXA raises the risk of blood clots.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

tranexamic acid (TXA)

What this could lead to

If it works, this could become a standard way to reduce bleeding and transfusions in colorectal surgery.

What could go wrong

This is a mid-stage trial with 394 participants, so results may not apply to all patients. TXA could increase the risk of dangerous blood clots.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BLEEDING are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Hemorrhage hemorrhagic disease Thromboembolism venous thromboembolism

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Cleveland Clinic Fairview Hospital

    RECRUITING

    Cleveland, Ohio, 44111, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••